Innovation Pharmaceuticals Inc (IPIX)

[KMBJN]

Thanks. Goofy how they report median duration of SOM on the entire population of 21 subjects that received brilacidin, instead of just the 9 who got SOM. The duration of SOM for the 12 subjects who didn't get SOM was obviously 0, so the 0 statistic of median SOM duration across the brilacidin population is meaningless / not at all descriptive of the duration of SOM for those who actually received brilacidin and had SOM.

Likewise for the placebo group - why not report the median duration for only those who got SOM, not the entire group (which includes those who didn't get SOM)?